Michael Matson
Stock Analyst at Needham
(2.66)
# 2,066
Out of 4,711 analysts
21
Total ratings
66.67%
Success rate
12.41%
Average return
Main Sectors:
Stocks Rated by Michael Matson
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
TFX Teleflex | Maintains: Buy | $408 → $423 | $178.16 | +137.43% | 4 | Jan 31, 2020 | |
INGN Inogen | Upgrades: Buy | $90 | $8.48 | +961.32% | 2 | Nov 6, 2019 | |
MMSI Merit Medical Systems | Initiates: Buy | $53 | $98.22 | -46.04% | 1 | Apr 20, 2018 | |
GMED Globus Medical | Upgrades: Buy | n/a | $82.63 | - | 1 | Apr 4, 2018 | |
RMD ResMed | Upgrades: Hold | n/a | $237.27 | - | 1 | Jan 23, 2018 | |
BSX Boston Scientific | Upgrades: Strong Buy | n/a | $88.95 | - | 1 | Dec 8, 2017 | |
LIVN LivaNova | Upgrades: Buy | n/a | $47.59 | - | 2 | Sep 15, 2017 | |
SYK Stryker | Upgrades: Hold | n/a | $364.60 | - | 4 | Aug 25, 2017 | |
MBLY Mobileye | Downgrades: Hold | n/a | $17.51 | - | 1 | Mar 14, 2017 | |
HOLX Hologic | Upgrades: Buy | n/a | $71.65 | - | 2 | Feb 15, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.50 | - | 1 | Mar 3, 2016 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.25 | - | 1 | Feb 24, 2016 |
Teleflex
Jan 31, 2020
Maintains: Buy
Price Target: $408 → $423
Current: $178.16
Upside: +137.43%
Inogen
Nov 6, 2019
Upgrades: Buy
Price Target: $90
Current: $8.48
Upside: +961.32%
Merit Medical Systems
Apr 20, 2018
Initiates: Buy
Price Target: $53
Current: $98.22
Upside: -46.04%
Globus Medical
Apr 4, 2018
Upgrades: Buy
Price Target: n/a
Current: $82.63
Upside: -
ResMed
Jan 23, 2018
Upgrades: Hold
Price Target: n/a
Current: $237.27
Upside: -
Boston Scientific
Dec 8, 2017
Upgrades: Strong Buy
Price Target: n/a
Current: $88.95
Upside: -
LivaNova
Sep 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $47.59
Upside: -
Stryker
Aug 25, 2017
Upgrades: Hold
Price Target: n/a
Current: $364.60
Upside: -
Mobileye
Mar 14, 2017
Downgrades: Hold
Price Target: n/a
Current: $17.51
Upside: -
Hologic
Feb 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $71.65
Upside: -
Mar 3, 2016
Downgrades: Neutral
Price Target: n/a
Current: $2.50
Upside: -
Feb 24, 2016
Downgrades: Hold
Price Target: n/a
Current: $1.25
Upside: -